- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.11 Å
- Oligo State
- homo-tetramer
- Ligands
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 6 residues within 4Å:- Chain A: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.3: 3 residues within 4Å:- Chain A: R.44, S.45, Y.487
Ligand excluded by PLIPSO4.4: 4 residues within 4Å:- Chain A: T.63, G.64, L.65, Q.440
Ligand excluded by PLIPSO4.5: 4 residues within 4Å:- Chain A: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.6: 1 residues within 4Å:- Chain A: K.473
Ligand excluded by PLIPSO4.10: 7 residues within 4Å:- Chain A: S.242
- Chain B: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.11: 2 residues within 4Å:- Chain B: R.44, S.45
Ligand excluded by PLIPSO4.12: 4 residues within 4Å:- Chain B: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain B: G.193, K.194, S.242, G.243
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain B: K.321, R.329
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain B: R.44, S.465, Y.487
Ligand excluded by PLIPSO4.18: 4 residues within 4Å:- Chain C: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.19: 6 residues within 4Å:- Chain C: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.20: 2 residues within 4Å:- Chain C: R.44, S.45
Ligand excluded by PLIPSO4.23: 7 residues within 4Å:- Chain C: S.242
- Chain D: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain D: R.44, S.45
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain D: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.26: 5 residues within 4Å:- Chain D: G.193, K.194, L.241, S.242, G.243
Ligand excluded by PLIP- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 8 residues within 4Å:- Chain A: D.127, F.128, W.179, N.234, E.235, E.340, W.381, F.397
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:W.179, A:E.235
GOL.21: 8 residues within 4Å:- Chain C: D.127, F.128, W.179, N.234, E.235, E.340, W.381, F.397
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:W.179, C:N.234, C:E.235, C:W.381
- Water bridges: C:Y.244
- 2 x IFM: 5-HYDROXYMETHYL-3,4-DIHYDROXYPIPERIDINE(Non-covalent)
IFM.16: 11 residues within 4Å:- Chain B: D.127, F.128, W.179, N.234, E.235, F.246, Y.313, E.340, C.342, W.381, N.396
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.127, B:D.127, B:E.340
IFM.27: 10 residues within 4Å:- Chain D: D.127, F.128, W.179, E.235, F.246, Y.313, E.340, S.345, W.381, N.396
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:D.127, D:D.127, D:E.340, D:N.396
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lieberman, R.L. et al., Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease. Nat.Chem.Biol. (2007)
- Release Date
- 2006-12-26
- Peptides
- Glucosylceramidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
SMTL ID : 2nsx.6 (8 other biounits)
Structure of acid-beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease
Glucosylceramidase
Toggle Identical (ABCD)Related Entries With Identical Sequence
1ogs.1 | 1ogs.2 | 1y7v.1 | 1y7v.2 | 1y7v.3 | 1y7v.4 | 1y7v.5 | 1y7v.6 | 2f61.1 | 2f61.2 | 2j25.1 | 2j25.2 | 2nsx.1 | 2nsx.2 | 2nsx.3 | 2nsx.4 | 2nsx.5 | 2nsx.7 | 2nsx.8 | 2nsx.9 | 2nt0.1 | 2nt0.2 | 2nt0.3 | 2nt0.4 | 2nt1.1 | 2nt1.2 | 2nt1.3 | 2nt1.4 | 2nt1.5 | 3gxd.1 more...less...3gxf.1 | 3gxf.2 | 3gxi.1 | 3gxi.2 | 3gxi.3 | 3gxi.4 | 3gxm.1 | 3gxm.2 | 3gxm.3 | 3gxm.4 | 3rik.1 | 3rik.2 | 3ril.1 | 3ril.2 | 6moz.1 | 6moz.2 | 6q1n.1 | 6q1n.2 | 6q1p.1 | 6q1p.2 | 6q1p.3 | 6q6k.1 | 6q6l.1 | 6q6n.1 | 6tjj.1 | 6tjj.2 | 6ytp.1 | 6ytp.2 | 6yut.1 | 6yut.2 | 6yv3.1 | 6yv3.2 | 6z39.1 | 8p3e.1 | 8p41.1 | 8p41.2